Financhill
Sell
27

ENVX Quote, Financials, Valuation and Earnings

Last price:
$7.88
Seasonality move :
21.02%
Day range:
$7.65 - $8.40
52-week range:
$5.70 - $18.68
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
62.00x
P/B ratio:
6.33x
Volume:
5.8M
Avg. volume:
6.1M
1-year change:
4.21%
Market cap:
$1.6B
Revenue:
$23.1M
EPS (TTM):
-$1.45

ENVX Analysts' Consensus Rating

The 11 analysts providing 12-month price projections for Enovix shares anticipate an average target of $27.08, ranging from a low estimate of $10.00 to a high estimate of $100.00. This average target implies a growth of 231.5% compared to the current stock price of $8.17.

Consensus Price Target

$27.08

Highest Price Target

$100.00

Lowest Price Target

$10.00

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Analyst Ratings

6M Ago 1M Ago Current
Buy 10 9 9

Hold 1 2 2

Sell 0 0 0
Consensus Buy Buy Buy

ENVX Recommendation Trends

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is CyberArk The Next Big Cybersecurity Stock?
Is CyberArk The Next Big Cybersecurity Stock?

CyberArk Software (NASDAQ: CYBR) recently reported phenomenal quarter numbers, passing…

Is the Market Going to Go Lower?
Is the Market Going to Go Lower?

The last month has been extremely difficult for the stock…

2 Dividend Stocks to Buy in a Recession
2 Dividend Stocks to Buy in a Recession

While many economists and investors initially expected 2025 to be…

Stock Ideas

Buy
53
Is AAPL Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 35x

Buy
54
Is NVDA Stock a Buy?

Market Cap: $2.9T
P/E Ratio: 41x

Buy
51
Is MSFT Stock a Buy?

Market Cap: $2.9T
P/E Ratio: 33x

Alerts

Buy
52
RGC alert for Mar 18

Regencell Bioscience Holdings [RGC] is up 73.51% over the past day.

Buy
63
EXOD alert for Mar 18

Exodus Movement [EXOD] is down 3.96% over the past day.

Sell
45
MNPR alert for Mar 18

Monopar Therapeutics [MNPR] is up 0.93% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock